Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parsaclisib + CHOP in Untreated Peripheral T-cell Lymphoma
NCT05238064Phase 2Not yet recruiting
- Sponsor
- Fudan University
- Start
- Mar 2022
- Primary completion
- Mar 2025
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of parsaclisib in peripheral T-cell lymphoma (PTCL), sponsored by Fudan University. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
parsaclisib
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT05238064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05238064.